NPPA: These three medicines are 50% costlier now

These drugs are used as the first line of treatment and are important to the public health programme of the country, the NPPA

213
NPPA Price of drugs

Last Updated on July 7, 2021 by The Health Master

The national drug pricing regulator NPPA on Friday said it has allowed a one-time increase of 50 per cent in the ceiling prices of nine scheduled formulations of three drugs – Carbamazepine, Ranitidine and Ibuprofen – to ensure their availability vide notification No. S.O. 2654(E) dated 01-07-2021.

These drugs are used as the first line of treatment and are important to the public health programme of the country, the National Pharmaceutical Pricing Authority (NPPA) said in its order.

Detail of these drugs are as under:

Sl. No.Name of the Scheduled FormulationDosage form & StrengthUnitCeiling Price (Rs.)Existing S.O. No. & Date
(1)(2)(3)(4)(5)6(a)6(b)
1.CarbamazepineOral Liquid 100 mg/5ml1 ml0.291330(E) Sl. No. 13925.03.2021
2.CarbamazepineCR Tablet 200 mg1 tablet2.341330(E) Sl. No. 14025.03.2021
3.CarbamazepineCR Tablet 400 mg1 tablet4.611330(E) Sl. No. 14125.03.2021
4.CarbamazepineTablet 100 mg1 tablet1.021330(E) Sl. No. 14225.03.2021
5.RanitidineOral Liquid 75 mg/5ml1 ml1.081330(E) Sl. No. 72225.03.2021
6.RanitidineTablet 150 mg1 tablet1.101330(E) Sl. No. 72325.03.2021
7.RanitidineInjection 25mg/ml1 ml2.431330(E) Sl. No. 72425.03.2021
8.IbuprofenTablet 200 mg1 tablet0.591330(E) Sl. No. 43125.03.2021
9.IbuprofenTablet 400 mg1 tablet1.041330(E) Sl. No. 43225.03.2021

NPPA, in its meeting on June 28, deliberated upon the case of upward price revision of the formulations of these drugs under Para 19 of Drugs (Prices Control) Order, 2013 (DPCO 2013) and noted that the scheduled formulations being considered for upward price revision are low-priced drugs and have been under repeated price controls, it added.

DPCO NPPA

While carbamazepine is an anti-epileptic drug, ranitidine is used for the treatment of ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Ibuprofen is used to relieve pain from various conditions such as headache, dental pain, menstrual cramps, muscle aches, or arthritis.

The National Pharmaceutical Pricing Authority (NPPA) said it is of the considered view that unviability of these formulations should not lead to a situation, where these drugs become unavailable in the market and the public is forced to switch to costly alternatives.

To address the situation arising due to repeated price control, a one-time price increase of 50 per cent from the current ceiling price is being considered in public interest as an exceptional measure as advised by the Standing Committee on Affordable Medicines and Health Products (SCAMHP), NPPA said.

Accordingly, “NPPA invokes extraordinary powers in public interest under Para 19 of DPCO 2013 for upward revision of the ceiling prices of the nine scheduled formulations of 3 drugs by giving one time increase of 50 percent from the present ceiling price,” it added.

The regulator was constituted as an independent regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.

NPPA provides ceiling price to all drugs notified under Schedule-1 of the DPCO 2013, and monitors annual price increase for these and the non-scheduled drugs.

Latest Notifications: DPCO / NPPA

Latest Notifications: D&C Rules 1945

Latest Notifications: D&C Act 1940

NPPA fixes retail prices of 3 formulations

NPPA fixes retail prices of 12 formulations

NPPA fixes retail prices of 2 formulations

NPPA fixes retail price of 41 formulations

NPPA fixes retail price of 1 formulation

NPPA fixes retail price of 36, revises of 889 formulations

Busting Myths of Vaccination

172 Drug Inspectors appointed as Medical Device Officer

These 5 Pharma giants join hands to test oral C-19 drug

DCGI denied approval for final trial of Sputnik Light to Dr…

NPPA fixes retail prices of 3 formulations

DCGI allows Cipla to import Moderna vaccine in India

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner